Levels of DUXAP8 detected in neuroblastoma tumor tissues have been higher in T4 stage than in T1 stage, and elevated DUXAP8 expression is associated with worse prognosis (Nie et al., 2020). This evidence concerns the gene DUXAP8 and neoplasm.